Please login to the form below

Not currently logged in
Email:
Password:

ShangPharma

This page shows the latest ShangPharma news and features for those working in and with pharma, biotech and healthcare.

Merck & Co adds to immunotherapy again with $773m Tilos buy

Merck & Co adds to immunotherapy again with $773m Tilos buy

Additional investment was provided by ShangPharma Innovation Fund.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • ShangPharma hires Biogen exec ShangPharma hires Biogen exec

    He now moves to China to head science at ShangPharma, a clinical research organisation (CRO) which employs 2, 000 scientists. ... preferred small molecules and biologics drug discovery partner for biopharmaceutical companies,” said Michael Hui,

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics